Alternative ophthalmic drug delivery systems – Ophthalmology Management
For most conditions, ophthalmic medications are administered by the patient, be they drop or ointment, and require proper times and intervals for successful results. Unfortunately, some patients have a hard time following instructions, even with the best of intentions, and are not compliant. Then treatment and outcomes are doomed to be suboptimal. So, alternative drug delivery systems that do not require patient activity are attractive alternatives. Here’s a look at them, as well as a primer for coding those currently under investigation.
This article addresses the following subjects:
- What are some alternative drug delivery systems?
- How would this procedure (including implant) be coded?
- Outside of clinical trials, what is the reimbursement for Category III codes?
This article was published in Ophthalmology Management’s Coding & Reimbursement column, which is written by Corcoran’s Executive Vice-President, Suzanne Corcoran, COE. To view the entire article in Ophthalmology Management, click on the link below: